TANDEM DIABETES CARE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.12 USD | +0.43% |
|
+10.61% | +18.73% |
Presenter SpeechLarry Biegelsen (Analysts)All right. Welcome, everyone. I'm Larry Biegelsen, t...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Calendar
2024-05-01
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
35.12
USD
Average target price
34.86
USD
Spread / Average Target
-0.75%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.73% | 2.27B | |
| -2.89% | 185B | |
| -2.43% | 107B | |
| -4.10% | 67.55B | |
| +11.10% | 54.6B | |
| +15.86% | 47.42B | |
| +3.86% | 42.24B | |
| +9.55% | 28.24B | |
| +1.85% | 26.42B | |
| +12.40% | 25.66B |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Transcript : Tandem Diabetes Care, Inc. Presents at 2022 Wells Fargo Healthcare Conference, Sep-08-2022 01
